Norplant and other implantable contraceptives

Clinical Obstetrics and Gynecology

Volumn 44, Issue 1, 2001, Pages 92-100

  Kovalevsky, George ^a   Barnhart, Kurt ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; ETONOGESTREL; LEVONORGESTREL; NOMEGESTROL ACETATE;

CONTRACEPTION; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG FORMULATION; DRUG IMPLANTATION; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; MENSTRUATION DISORDER; REVIEW;

BIODEGRADATION, ENVIRONMENTAL; CONTRACEPTIVE AGENTS, FEMALE; DRUG IMPLANTS; FEMALE; HUMANS; LEVONORGESTREL; PATIENT SATISFACTION; PATIENT SELECTION; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0035131067     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200103000-00012     Document Type: Review

References (21)

1. A new delivery system for contraceptive steroids
2. Hormonal implants: Contraception for a new century
3. Manufacturer moves to settle Norplant claims
4. Ovarian endocrine function through five years of continuous treatment with Norplant subdermal contraceptive implants
5. Neuroendocrine mechanism of anovulation in users of contraceptive subdermal implant of nomegestrol acetate (Uniplant)
6. Efficacy and continuation rates of Norplant in Pakistan
7. Levonorgestrel capsule implants in the United States: A 5-year study
8. Implantable hormonal and emergency contraception
9. Comparison of local signs and symptoms after the insertion of Norplant implants with and without a scalpel
10. Complications and risk factors associated with the removal of Norplant implants
11. One-year experience with subdermal contraceptive implants in the United States
12. Changes in the menstrual bleeding of users of a subdermal contraceptive implant of nomegestrol acetate (Uniplant) do not influence sexual frequency, sexual desire, or sexual enjoyment
13. Menstrual blood loss with contraceptive subdermal levonorgestrel implants
14. The effect of mefenamic acid on controlling irregular uterine bleeding secondary to Norplant use
15. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant
16. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or Tcu 380Ag intrauterine contraceptive devices
17. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers
18. Contraceptive implants and injectables: Recent developments